References
- Chang MH. Hepatitis B virus infection. Semin Fetal Neonatal Med. 2007; 3(12): 160-7. PubMed | Google Scholar
- Barker LF, Shulman NR, R Murray et al. Transmission of serum hepatitis. JAMA. 1996 Sep 11; 276(10): 841-4. PubMed
- Williams R. Global challenges in liver disease.
Hepatology. 2006; 3(44): 521-6. PubMed | Google
Scholar
- Redd JT, Baumbach J, Kohn W et al. Patient-to-patient transmission of hepatitis B virus associated with oral surgery. J Infect Dis. 2007 May 1; 195(9): 1311-4. Epub 2007 Mar 21. PubMed | Google Scholar
- Alter MJ. Epidemiology and prevention of hepatitis B. Semin Liver Dis. 2003 Feb; 23(1): 39-46. PubMed | Google Scholar
- Meffre C, Le Strat Y, Delarocque-Astagneau E, Antona D, Desenclos JC et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Med Virol. 2010 Apr; 82(4): 546-55. PubMed | Google Scholar
- Yun-Fan Liaw, Chia-Ming Chu. Hepatitis B virus infection. Lancet. 2009; 373(9663): 582-592. Google Scholar
- Ryan KJ and Ray CG (editors). Sherris Medical Microbiology.
McGraw Hill. 2004; 4: 551-2.
- WHO. Hépatite C. L'hépatite C est une maladie infectieuse transmissible par le sang et due au virus de l'hépatite C, qui s'attaque au foie. January 2, 2009.
- Marcellin P. Hepatitis C: the clinical spectrum
of the disease. Hepatol. 1999; 31 Suppl 1: 9-16. PubMed | Google
Scholar
- Dega H, Frances C, Dupin N, Lebre C, Simantov A,
Callot C, Chosidow O et al. Itching and hepatitis
C. Annals of Dermatology and Venereology. 1998; 125(1):
9-12.
- Kapoor D, Saxena R, Sood B, Sarin SK. Blood transfusion
practices in India: results of a national survey. Indian J Gastroenterol.
2000 Apr-Jun; 19(2): 64-7. PubMed | Google
Scholar
- Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M.
Unsafe injections in the developing world and transmission
of blood terminal pathogens.Bull World Health Organ.
1999; 77(10): 789-800. PubMed | Google
Scholar
- WHO. Hepatitis C prevalence overall. Wkly Epidemiol Rec. 1999; 49: 421-8.
- Alter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States in 1988 through 1994. 1999; 341: 556-62. Google Scholar
- Ruiz
J, Molitor F, Plagenhoef J. Trends in hepatitis C
and HIV infection among inmates reviews entering prisons
in California in
1994 versus 1999. AIDS.
2002; 16(16): 2236-8. Google
Scholar
- Campbell J Hagan H, M Latka, Garfein R Golub E, M Coady, Thomas D, Strathdee S. High prevalence use of alcohol Among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend. 2006 Feb 28; 81(3): 259-65. Epub 2005 Aug 29. PubMed
- McGovern B, Wurcel A, Kim A, Schulze zur Wiesch
J, Bica I, Zaman M, Timm J, Walker B,
Lauer G. Acute infection in incarcerated injection
drug users. Clin Infect Dis. 2006
Jun 15; 42(12): 1663-70. Epub 2006 May 11. PubMed
- Meffre C, Le Strat Y, Delarocque-Astagneau E, Antona
D, Desenclos JC. Prevalence of hepatitis B and C in
France in 2004. InVS
St. Maurice. 2006. PubMed | Google
Scholar
- Frank C, Mohamed M, Strickland G, Lavanchy D, Arthur
R, Magder L, El Khoby T, Abdel-Wahab Y, Aly Ohn E,
Anwar W, Sallam I. The role of parenteral therapy antischistosomal
in the spread
of hepatitis
C virus in Egypt. Lancet. 2000; 9207 (355): 887-91. PubMed | Google
Scholar
- Cohen J. New report halves the number of people infected with hepatitis C worldwide. April 21, 2017.
- Bonino
F, Chiaberge E, Maran E, Piantino P. Serological markers
of HBV infectivity. Ann Ist Super Sanita. 1987; 24(2):
217-23. PubMed
- Engvall E, Perlman P. Enzyme-linked immunosorbent
assay (ELISA): quantitative assay of immunoglobulin
G. Immunochemistry. 1971 Sep; 8(9): 871-4. PubMed | Google
Scholar
- Goldsby RA, Kindt TJ, Osborne BA and Kuby J. Enzyme-Linked Immunosorbent Assay in Immunology. 2003; 148-150.
- Ntagirabiri R, Niyongabo T, Ndayiragije E, Baransaka. The prevalence of hepatitis B in Burundi national survey. Afr J Hepatol Gastroenterol. 2013; 7: 199-2035.